Skip to main content
ZNTL logo

ZNTL · Zentalis Pharmaceuticals, Inc.

$5.11 +0.54 (+11.82%) At close · Jul 17
Market Cap
$363.76M
Shares
71,186,348

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 102
Total Value: $102,477,280
Total Shares: 43,688,837
Showing 1–100 of 106 holdings by value · page 1 of 2

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 101 13F filers
Top Holder
9.2%
Jun 2023 → Mar 2026 · range 9.2% – 26.4%
of institutional value
Top 5
36.9%
Jun 2023 → Mar 2026 · range 35.7% – 55.9%
of institutional value
Top 10
55.0%
Jun 2023 → Mar 2026 · range 53.9% – 75.7%
of institutional value
HHI
418
Jun 2023 → Mar 2026 · range 416 – 889
Broadly held
Showing 100 of 106
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1725160 CUSIP 98943L107 13F (30d) 2 filings 2 filers Visit website Investor relations